Loading…

CONMED Corporation announced a definitive agreement to acquire In2Bones Global for $145 million at closing plus up to $110 million in earnout payments. In2Bones develops medical devices for extremities surgery.
“CONMED Corporation today announced a definitive agreement to acquire privately-held In2Bones Global, Inc., on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period.”conmed.gcs-web.com
Summarized from public sources; check the original articles before acting on it.